Nanomedicine, Volume IIA: Biocompatibility

© 2003 Robert A. Freitas Jr. All Rights Reserved.

Robert A. Freitas Jr., Nanomedicine, Volume IIA: Biocompatibility, Landes Bioscience, Georgetown, TX, 2003


References 2500-2599

2500. R.L. Goode, B.N. Reynolds, “Tobramycin-impregnated methylmethacrylate for mandible reconstruction,” Arch. Otolaryngol. Head Neck Surg. 118(February 1992):201-204.

2501. G.W. Bowyer, N. Cumberland, “Antibiotic release from impregnated pellets and beads,” J. Trauma 36(March 1994):331-335.

2502. K. Okahara, J. Kambayashi, T. Shibuya, T. Kawasaki, M. Sakon, Y. Dohi, Y. Oka, S. Ito, S. Miyake, “An infection-resistant PTFE vascular graft; spiral coiling of the graft with ofloxacin-bonded PTFE thread,” Eur. J. Vasc. Endovasc. Surg. 9(May 1995):408-414.

2503. J.S. Price, A.F. Tencer, D.M. Arm, G.A. Bohach, “Controlled release of antibiotics from coated orthopedic implants,” J. Biomed. Mater. Res. 30(March 1996):281-286.

2504. A.K. Gupta, D.F. Bandyk, B.L. Johnson, “In situ repair of mycotic abdominal aortic aneurysms with rifampin-bonded gelatin-impregnated Dacron grafts: a preliminary case report,” J. Vasc. Surg. 24(September 1996):472-476.

2505. D. Melliere, S. Zaouche, J.P. Becquemin, P. Desgranges, A. Cavillon, J. Tankovic, “Antibiotic-impregnated prostheses: eclectic indications,” J. Mal. Vasc. 21(1996):139-145 (Suppl A). In French.

2506. A.S. Younger, C.P. Duncan, B.A. Masri, R.W. McGraw, “The outcome of two-stage arthroplasty using a custom-made interval spacer to treat the infected hip,” J. Arthroplasty 12(September 1997):615-623.

2507. Y. Yamashita, A. Uchida, T. Yamakawa, Y. Shinto, N. Araki, K. Kato, “Treatment of chronic osteomyelitis using calcium hydroxyapatite ceramic implants impregnated with antibiotic,” Int. Orthop. 22(1998):247-251.

2508. S.H. McKellar, B.D. Allred, J.D. Marks, C.G. Cowley, D.C. Classen, S.C. Gardner, J.W. Long, “Treatment of infected left ventricular assist device using antibiotic-impregnated beads,” Ann. Thorac. Surg. 67(February 1999):554-555.

2509. T. Pasdeloup, “Infections due to foreign bodies: primary prevention,” Presse. Med. 28(27 November 1999):7-8 (Suppl 3). In French.

2510. R.C. Spencer, “Novel methods for the prevention of infection of intravascular devices,” J. Hosp. Infect. 43(December 1999):S127-S135.

2511. A.J. Tasman, F. Wallner, R. Neumeier, “Antibiotic impregnation of cartilage implants: diffusion kinetics of fluoroquinolones,” Laryngorhinootologie 79(January 2000):30-33. In German.

2512. R.L. Barrack, G. Engh, C. Rorabeck, J. Sawhney, M. Woolfrey, “Patient satisfaction and outcome after septic versus aseptic revision total knee arthroplasty,” J. Arthroplasty 15(December 2000):990-993.

2513. S. Yoshitatsu, T. Takagi, “A case of giant pencil-core granuloma,” J. Dermatol. 27(May 2000):329-332.

2514. N. Terasawa, S. Kishimoto, Y. Kibe, H. Takenaka, H. Yasuno, “Graphite foreign body granuloma,” Br. J. Dermatol. 141(October 1999):774-776.

2515. J. Genzer, K. Efimenko, “Creating long-lived superhydrophobic polymer surfaces through mechanically assembled monolayers,” Science 290(15 December 2000):2130-2133;; T. Wu, K. Efimenko, J. Genzer, “Preparing high-density polymer brushes by Mechanically Assisted Polymer Assembly (MAPA),” Macromolecules 34(2001):684-686;; K. Efimenko, J. Genzer, “Tuning the surface properties of elastomers using hydrocarbon-based mechanically assembled monolayers,” Mat. Res. Sac. Symp. Proc. 705(2002):DD10.3.1-DD10.3.6;

2516. Austin N. Kirschner, Stephen R. Wilson, “A Biosensor for Fullerenes and Carbon Nanotubes,” 8th Foresight Conference on Molecular Nanotechnology, November 2000;

2517. K. Hong, T. Kinoshita, J. Takeda, H. Kozono, P. Pramoonjago, Y.U. Kim, K. Inoue, “Inhibition of the alternative C3 convertase and classical C5 convertase of complement by group A streptococcal M protein,” Infect. Immun. 58(August 1990):2535-2541.

2518. R. Kue, A. Sohrabi, D. Nagle, C. Frondoza, D. Hungerford, “Enhanced proliferation and osteocalcin production by human osteoblast-like MG63 cells on silicon nitride ceramic discs,” Biomaterials 20(July 1999):1195-1201.

2519. S. Dueland, P. Helgerud, J.I. Pedersen, T. Berg, C.A. Dorevon, “Plasma clearance, transfer, and distribution of vitamin D3 from intestinal lymph,” Am. J. Physiol. 245(October 1983):E326-E331.

2520. X.M. Pan, I. Staprans, T.E. Read, J.H. Rapp, “Cigarette smoke alters chylomicron metabolism in rats,” J. Vasc. Surg. 18(August 1993):161-167, 168-169 (discussion).

2521. M. Hultin, C. Carneheim, K. Rosenqvist, T. Olivecrona, “Intravenous lipid emulsions: removal mechanisms as compared to chylomicrons,” J. Lipid Res. 36(October 1995):2174-2184.

2522. M. Hultin, R. Savonen, T. Olivecrona, “Chylomicron metabolism in rats: lipolysis, recirculation of triglyceride-derived fatty acids in plasma FFA, and fate of core lipids as analyzed by compartmental modeling,” J. Lipid Res. 37(May 1996):1022-1036.

2523. J.W. Costerton, Z. Lewandowski, D.E. Caldwell, D.R. Korber, H.M. Lappin-Scott, “Microbial biofilms,” Annu. Rev. Microbiol. 49(1995):711-745.

2524. G.M. Matuschak, A.J. Lechner, “The yeast to hyphal transition following hematogenous candidiasis induces shock and organ injury independent of circulating tumor necrosis factor-alpha,” Crit. Care Med. 25(January 1997):111-120.

2525. K. Kim, C. Kim, Y. Byun, “Preparation of a PEG-grafted phospholipid Langmuir-Blodgett monolayer for blood-compatible material,” J. Biomed. Mater. Res. 52(15 December 2000):836-840.

2526. K. Ishihara, H. Oshida, Y. Endo, A. Watanabe, T. Ueda, N. Nakabayashi, “Effects of phospholipid adsorption on nonthrombogenicity of polymer with phospholipid polar group,” J. Biomed. Mater. Res. 27(October 1993):1309-1314; K. Ishihara, N. Nakabayashi, “Specific interaction between water-soluble phospholipid polymer and liposome,” J. Poly. Sci. 29(1991):831-835.

2527. A.S. Kohler, P.J. Parks, D.L. Mooradian, G.H. Rao, L.T. Furcht, “Platelet adhesion to novel phospholipid materials: modified phosphatidylcholine covalently immobilized to silica, polypropylene, and PTFE materials,” J. Biomed. Mater. Res. 32(October 1996):237-242.

2528. Patrick T. Cahalan, “Chapter 42. Bioinert Biomaterials: Are Their Properties Irreplaceable?” in Peter Zilla, Howard P. Greisler, eds., Tissue Engineering of Prosthetic Vascular Grafts, R.G. Landes Company, Austin TX, 1999, pp. 463-467.

2529. P.W. Baker, K.A. Rye, J.R. Gamble, M.A. Vadas, P.J. Barter, “Phospholipid composition of reconstituted high density lipoproteins influences their ability to inhibit endothelial cell adhesion molecule expression,” J. Lipid Res. 41(August 2000):1261-1267.

2530. A. Raudino, A. Cambria, M.G. Sarpietro, “Binding of lipid vesicles to protein-coated solid polymer surfaces: A model for cell adhesion to artificial biocompatible materials,” J. Colloid. Interface Sci. 231(1 November 2000):66-73.

2531. Y.J. Li, T. Nakaya, Z. Zhang, M. Kodama, “Blood compatible phospholipid-containing polyurethanes: synthesis, characterization, and blood compatibility evaluation,” J. Biomater. Appl. 12(October 1997):167-191.

2532. Y.J. Li, T. Yokawa, K.H. Matthews, T.M. Chen, Y.F. Wang, M. Kodama, T. Nakaya, “Synthesis and blood compatibility evaluation of segmented polyurethanes based on cholesterol and phosphatidylcholine analogous moieties,” Biomaterials 17(November 1996):2179-2189.

2533. K. Ishihara, Y. Iwasaki, “Reduced protein adsorption on novel phospholipid polymers,” J. Biomater. Appl. 13(October 1998):111-127; K. Ishihara, H. Nomura, T. Mihara, K. Kurita, Y. Iwasaki, N. Nakabayashi, “Why do phospholipid polymers reduce protein adsorption?” J. Biomed. Mater. Res. 39(February 1998):323-330; Y. Iwasaki, A. Fujiike, K. Kurita, K. Ishihara, N. Nakabayashi, “Protein adsorption and platelet adhesion on polymer surfaces having phospholipid polar group connected with oxyethylene chain,” J. Biomater. Sci. Polym. Ed. 8(1996):91-102.

2534. R.G. Chapman, E. Oastuni, M.N. Liang, G. Melulent, E. Kim, L. Yan, G. Pier, H.S. Warren, G.M. Whitesides, “Polymeric thin films that resist the adsorption of proteins and the adhesion of bacteria,” Langmuir 17(2001):1225-1233.

2535. S.W. Kim, J. Feijen, “Surface modification of polymers for improved blood compatibility,” Crit. Rev. Biocompat. 1(1985):229-260.

2536. Mark S. Munro, Robert C. Eberhart, Nancy J. Maki, Bruce E. Brink, William J. Fry, “Thromboresistant Slkyl Derivatized Polyurethanes,” Am. Soc. Artif. Intern. Organs 6(April-June 1983):65-75.

2537. S.D. Riccitelli, R.G. Schlatterer, J.A. Hendrix, G.B. Williams, R.C. Eberhart, “Albumin Coatings Resistant to Shear-Induced Desorption,” Trans. Am. Soc. Artif. Intern. Organs 31(1985):250-255.

2538. Robert C. Eberhart, “Surface Treatments to Improve the Albumin Affinity and Blood Compatibility of Polymers,” IEEE Engng. Med. Biol. Mag. (June 1989):26-29.

2539. Mark J. Walport, “Complement,” New Engl. J. Med. 344(5 April 2001):1058-1066.

2540. Kevin C. Olbrich, Thomas T. Andersen, Frank A. Blumenstock, Rena Bizios, “Surfaces modified with covalently-immobilized adhesive peptides affect fibroblast population motility,” Biomaterials 17(1996):759-764.

2541. A.D. Kirk, D.M. Harlan, N.N. Armstrong, T.A. Davis, Y. Dong, G.S. Gray, X. Hong, D. Thomas, J.H. Fechner Jr, S.J. Knechtle, “CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates,” Proc. Natl. Acad. Sci. (USA) 94(5 August 1997):8789-8794.

2542. Heidi E. Warriner, Stefan H.J. Idziak, Nelle L. Slack, Patrick Davidson, Cyrus R. Safinya, “Lamellar biogels: Fluid-membrane-based hydrogels containing polymer lipids,” Science 271(16 February 1996):969-973.

2543. Jeffrey M. Critchfield, Michael K. Racke, Juan Carlos Zuniga-Pflucker, Barbara Cannella, Cedric S. Raine, Joan Goverman, Michael J. Lenardo, “T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis,” Science 263(25 February 1994):1139-1143.

2544. Tom G. Schwan, B. Joseph Hinnebusch, “Bloodstream- versus tick-associated variants of a relapsing fever bacterium,” Science 280(19 June 1998):1938-1940.

2545. Luk Van Parijs, Abul K. Abbas, “Homeostasis and self-tolerance in the immune system: turning lymphocytes off,” Science 280(10 April 1998):243-248.

2546. Hidde L. Ploegh, “Viral strategies of immune evasion,” Science 280(10 April 1998):248-253.

2547. Samson A. Jenekhe, X. Linda Chen, “Self-assembled aggregates of rod-coil block copolymers and their solubilization and encapsulation of fullerenes,” Science 279(20 march 1998):1903-1907.

2548. Zi-Shan Zhao, Francesca Granucci, Lily Yeh, Priscilla A. Schaffer, Harvey Cantor, “Molecular mimicry by herpes simplex virus-type 1: Autoimmune disease after viral infection,” Science 279(27 February 1998):1344-1347.

2549. Lara K. Mahal, Kevin J. Yarema, Carolyn R. Bertozzi, “Engineering chemical reactivity on cell surfaces through oligosaccharide biosynthesis,” Science 276(16 May 1997):1125-1128; K.J. Yarema, L.K. Mahal, R.E. Bruehl, E.C. Rodriguez, C.R. Bertozzi, “Metabolic delivery of ketone groups to sialic acid residues. Application to cell surface glycoform engineering,” J. Biol. Chem. 273(20 November 1998):31168-31179;

2550. Warren D. Shlomchik, Matthew S. Couzens, Cheng Bi Tang, Jennifer McNiff, Marie E. Robert, Jinli Liu, Mark J. Shlomchik, Stephen G. Emerson, “Prevention of graft versus host disease by inactivation of host antigen-presenting cells,” Science 285(16 July 1999):412-415.

2551. Trisha Gura, “Innate immunity: ancient system gets new respect,” Science 291(16 March 2001):2068-2071.

2552. J.L. Bahr, E.T. Mickelson, M.J. Bronikowski, R.E. Smalley, J.M. Tour, “Dissolution of small diameter single-wall carbon nanotubes in organic solvents?” Chem. Commun. (2001):193-194.

2553. Todd B. Reynolds, Gerald R. Fink, “Bakers’ yeast, a model for fungal biofilm formation,” Science 291(2 February 2001):878-881.

2554. Kai-Chien Chang, David F.J. Tees, Daniel A. Hammer, “The state diagram for cell adhesion under flow: Leukocyte rolling and firm adhesion,” Proc. Natl. Acad. Sci. (USA) 97(10 October 2000):11262-11267.

2555. Bali Pulendran, Karolina Palucka, Jacques Banchereau, “Sensing pathogens and tuning immune responses,” Science 293(13 July 2001):253-256.

2556. F.P. Siegal, N. Kadowaki, M. Shodell, P.A. Fitzgerald-Bocarsly, K. Shah, S. Ho, S. Antonenko, Y.J. Liu, “The nature of the principal type 1 interferon-producing cells in human blood,” Science 284(11 June 1999):1835-1837, 1746 (comment); M. Cella, D. Jarrossay, F. Facchetti, O. Alebardi, H. Nakajima, A. Lanzavecchia, M. Colonna, “Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon,” Nature Med. 5(August 1999):919-923, 868-870 (comment).

2557. J. Banchereau, R.M. Steinman, “Dendritic cells and the control of immunity,” Nature 392(19 March 1998):245-252; J. Banchereau, F. Briere, C. Caux, J. Davoust, S. Lebecque, Y.J. Liu, B. Pulendran, K. Palucka, “Immunobiology of dendritic cells,” Annu. Rev. Immunol. 18(2000):767-811.

2558. A. Lanzavecchia, F. Sallusto, “Dynamics of T lymphocyte responses: intermediates, effectors, and memory cells,” Science 290(6 October 2000):92-97; “The instructive role of dendritic cells on T cell responses: lineages, plasticity and kinetics,” Curr. Opin. Immunol. 13(June 2001):291-298.

2559. M. Moser, K.M. Murphy, “Dendritic cell regulation of TH1-TH2 development,” Nature Immunol. 1(September 2000):199-205; A. Langenkamp, M. Messi, A. Lanzavecchia, F. Sallusto, “Kinetics of dendritic cell activation: impact on priming of TH1, TH2 and nonpolarized T cells,” Nat. Immunol. 1(October 2000):311-316.

2560. C.A. Janeway Jr., “Approaching the asymptote? Evolution and revolution in immunology,” Cold Spring Harbor Symp. Quant. Biol. 54(1989):1-13.

2561. J.A. Hoffmann, F.C. Kafatos, C.A. Janeway, R.A. Ezekowitz, “Phylogenetic perspectives in innate immunity,” Science 284(21 May 1999):1313-1318.

2562. R. Medzhitov, C. Janeway Jr., “Innate immune recognition: mechanisms and pathways,” Immunol. Rev. 173(February 2000):89-97.

2563. A. Aderem, R.J. Ulevitch, “Toll-like receptors in the induction of the innate immune response,” Nature 406(17 August 2000):782-787.

2564. B.W. Bainbridge, R.P. Darveau, “Porphyromonas gingivalis lipopolysaccharide: an unusual pattern recognition receptor ligand for the innate host defense system,” Acta Odontol. Scand. 59(June 2001):131-138.

2565. J. Pugin et al, “CD14 is a pattern recognition receptor,” Immunity 1(September 1994):509-516; P.D. Stahl, R.A. Ezekowitz, “The mannose receptor is a pattern recognition receptor involved in host defense,” Curr. Opin. Immunol. 10(February 1998):50-55.

2566. Mikhail V. Korobov, Allan L. Smith, “Solubility of the Fullerenes,” in K.M. Kadish, R.S. Ruoff, eds., Fullerenes: Chemistry, Physics, and Technology, John Wiley and Sons, New York, 2000, pp. 53-90.

2567. S.R. Wilson, Q. Lu, J. Cao, H. Zhao, Y. Wu, D.I. Schuster, Proc. Electrochem. Soc. 95(1995):1179 et seq.

2568. S.H. Friedman, D.L. DeCamp, R.P. Sijbesma, G. Srdanov, F. Wudl, G.L. Kenyon, “Inhibition of HIV-1 protease by fullerene derivatives: model building studies and experimental verification,” J. Am. Chem. Soc. 115(1993):6506-6509; H. Mi, M.E. Tuckerman, D.I. Schuster, S.R. Wilson, “A molecular dynamics study of HIV-1 protease complexes with C60 and fullerene-based anti-viral agents,” Proc. Electrochem. Soc. 99(1999):256-269; (abstract)

2569. Yi-Zhong An, Chi-Hong B. Chen, Jamey L. Anderson, David S. Sigman, Christopher S. Foote, Yves Rubin, “Sequence-specific modification of guanosine in DNA by a C60-linked deoxyoligonucleotide: evidence for a non-singlet oxygen mechanism,” Tetrahedron 52(1996):5179-5189.

2570. A. Bianco, F. Gasparrini, M. Maggini, D. Misiti, A. Polese, M. Prato, G. Scorrano, C. Toniolo, C. Villani, “Molecular recognition by a silica-bound fullerene derivative,” J. Am. Chem. Soc. 119(1997):7550-7554.

2571. Jovana Simic-Krstic, “Effects of C60(OH)24 on microtubule assembly,” Archive of Oncology 5(1997):143-145; (abstract)

2572. L. Wenzhu, K. Qian, W. Huang, Z. Zhang, W. Chen, Chin. Phys. Lett. 11(1994):207 et seq; K. Qian, Q. Yan, W. Huang, W. Li, Shengwu Hwaxue Yu Shengwu Wuli Jinzhan 24(1997):237 et seq.

2573. A.S. Boutorine, H. Tokuyama, M. Takasugi, H. Isobe, E. Nakamura, C. Helene, “Fullerene-oligonucleotide conjugates: photo-induced sequence-specific DNA cleavage,” Angew. Chem. Int. Ed. Engl. 33(1994):2462-2465, Angew. Chem. 106(1994):2526-2529.

2574. C. Lichenstein, W. Nellen, Antisense Technology: A Practical Approach, Oxford University Press, New York, 1997; C.A. Stein, A.M. Krieg, Applied Antisense Oligonucleotide Technology, Wiley-Liss, New York, 1998.

2575. N. Higashi, T. Inoue, M. Niwa, “Immobilization cleavage of DNA at cationic, self-assembled monolayers containing C60 on gold,” Chem. Commun. (1997):1507-1508.

2576. N. Nakajima, C. Nishi, F.-M. Li, Y. Ikada, Fullerene Sci. Technol. 4(1996):1 et seq.

2577. W.-D. Huang, K.-X. Qian, W.-Z. Li, Shengwu Huaxue Zazhi 12(1996):483 et seq.

2578. Y. Tabata, Y. Murakami, Y. Ikada, Proc. Int. Symp. Cont. Rel. Bioact. Mater. 24(1997):122 et seq.

2579. H.T. Tien, L.-G. Wang, X. Wang, A.L. Ottova, Bioelectrochem. Bioenerg. 42(1997):161-167.

2580. F. Cardullo, F. Diederich, L. Echegoyen, T. Habicher, N. Jayaraman, R.M. Leblanc, J.F. Stoddart, S. Wang, “Stable Langmuir and Langmuir-Blodgett films of fullerene-glycodendron conjugates,” Langmuir 14(1998):1955-1959.

2581. L.Y. Chiang, F.J. Lu, J.T. Lin, “Free radical scavenging activity of water-soluble fullerenols,” J. Chem. Soc. Chem. Commun. (1995):1283-1284; Y. Zhu, D. Sun, G. Liu, Z. Liu, R. Zhan, S. Liu, X. Gaodeng, Huaxue Xuebao 17(1996):1127 et seq; D. Sun, Y. Zhu, Z. Liu, G. Liu, X. Guo, R. Zhan, S. Liu, “Active oxygen radical scavenging ability of water-soluble fullerenols,” Chin. Sci. Bull. 42(1997):748-752; M. Arul Murugan, Bindu Gangadharan, P.P. Mathur, “Antioxidative effect of fullerenol on goat epididymal spermatozoa,” Asian J. Androl. 4(June 2002):149-152;

2582. K. Okuda, T. Mashino, M. Hirobe, Proc. Electrochem. Soc. 96(1997):411 et seq.

2583. Y. Yamakoshi, S. Sueyoshi, K. Fukuhara, N. Miyata, T. Masumizu, M. Kohno, “OH and O2-generation in aqueous C60 and C70 solutions by photoirradiation – an EPR study,” J. Am. Chem. Soc. 120(1998):12363-12364.

2584. D.B. Warheit, J.F. Hansen, M.C. Carakostas, M.A. Hartsky, Ann. Occup. Hyg. 38(1994):769 et seq.

2585. J. Cook, J. Sloan, M.L.H. Green, “Opening and filling carbon nanotubes,” Fullerene Sci. Technol. 5(1997):695 et seq; J.J. Davis, M.L.H. Green, H.A.O. Hill, Y.C. Leung, P.J. Sadler, J. Sloan, A.V. Xavier, S.C. Tsang, “The immobilisation of proteins in carbon nanotubes,” Inorg. Chim. Acta 272(1998):261.

2586. L.M. Lander, W.J. Brittain, E.A. Vogler, “Blood contact properties of surface immobilized
C60,” Langmuir 11(1995):375-376.

2587. S.F. Kiechel, G.T. Rodeheaver, J.J. Klawitter, M.T. Edgerton, R.F. Edlich, “The role of implant porosity on the development of infection,” Surg. Gynecol. Obstet. 144(January 1977):58-62.

2588. K. Merritt, J.W. Shafer, S.A. Brown, “Implant site infection rates with porous and dense materials,” J. Biomed. Mater. Res. 13(January 1979):101-108.

2589. J.P. Ranieri, R. Bellamkonda, J. Jacob, T.G. Vargo, J.A. Gardella, P. Aebischer, “Selective neuronal cell attachment to a covalently patterned monoamine on fluorinated ethylene propylene films,” J. Biomed. Mater. Res. 27(July 1993):917-925; J.P. Ranien, R. Bellamkonda, E.J. Bekos, J.A. Gardella Jr., H.J. Mathieu, L. Ruiz, P. Aebischer, “Spatial control of neuronal cell attachment and differentiation on covalently patterned laminin oligopeptide substrates,” Int. J. Dev. Neurosci. 12(December 1994):725-735.

2590. C.A. Ward, A. Koheil, W.R. Johnson, P.N. Madras, “Reduction in complement activation from biomaterials by removal of air nuclei from the surface roughness,” J. Biomed. Mater. Res. 18(March 1984):255-269.

2591. M.E. Norman, P. Williams, L. Illum, “Influence of block copolymers on the adsorption of plasma proteins to microspheres,” Biomaterials 14(February 1993):193-202.

2592. E. Mathiowitz et al, “Biologically erodable microspheres as potential oral drug delivery systems,” Nature 386(27 March 1997):410-414.

2593. M. Bianchi et al, “An inhibitor of macrophage arginine transport and nitric oxide production (CNI-1493) prevents acute inflammation and endotoxin lethality,” Mol. Med. 1(March 1995):254-266; P.S. Cohen, H. Nakshatri, J. Dennis, T. Caragine, M. Bianchi, A. Cerami, K.J. Tracey, “CNI-1493 inhibits monocyte/macrophage tumor necrosis factor by suppression of translation efficiency,” Proc. Natl. Acad. Sci. (USA) 93(30 April 1996):3967-3971.

2594. J. Yang, W. Denham, G. Carter, K.J. Tracey, J. Norman, “Macrophage pacification reduces rodent pancreatitis-induced hepatocellular injury through down-regulation of hepatic tumor necrosis factor alpha and interleukin-1beta,” Hepatology 28(November 1998):1282-1288; J. Yang, W. Denham, K.J. Tracey, H. Wang, A.A. Kramer, K.F. Salhab, J. Norman, “The physiologic consequences of macrophage pacification during severe acute pancreatitis,” Shock 10(September 1998):169-175.

2595. C. Granert, H. Abdalla, L. Lindquist, A. Diab, M. Bahkiet, K.J. Tracey, J. Andersson, “Suppression of macrophage activation with CNI-1493 increases survival in infant rats with systemic Haemophilus influenzae infection,” Infect. Immun. 68(September 2000):5329-5334.

2596. E.M. Nkamgueu, J.J. Adnet, J. Bernard, K. Zierold, L. Kilian, E. Jallot, H. Benhayoune, P. Bonhomme, “In vitro effects of zirconia and alumina particles on human blood monocyte-derived macrophages: X-ray microanalysis and flow cytometric studies,” J. Biomed. Mater. Res. 52(15 December 2000):587-594.

2597. N.M. Walsh, J.G. Hanly, R. Tremaine, S. Murray, “Cutaneous sarcoidosis and foreign bodies,” Am. J. Dermatopathol. 15(June 1993):203-207.

2598. D. Dziedzic, “Differential counts of B and T lymphocytes in the lymph nodes, circulating blood and spleen after inhalation of high concentrations of diesel exhaust,” J. Appl. Toxicol. 1(April 1981):111-115.

2599. Andrzej Huczko et al, “Physiological testing of carbon nanotubes: Are they asbestoslike?” Fullerene Sci. and Technol. 9(15 April 2001):251-254.


Last updated on 16 April 2004